Clinical Trial Update: A Study to Evaluate Sapablursen (Formerly ISIS 702843, IONIS-TMPRSS6-LRx) in Patients With Polycythemia Vera [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Sapablursen (formerly ISIS 702843, IONIS-TMPRSS6-LRx) in polycythemia vera; the study is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Sapablursen (sapablursen)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Phlebotomy Dependent Polycythemia Vera | Phase 2 | Status: ACTIVE_NOT_RECRUITING